
Science
FDA Clears Roche and Eli Lilly Alzheimer's Blood Test
The Elecsys pTau217 biomarker test helps identify Alzheimer's-related brain changes in patients aged 55 and older with cognitive decline.
Topic
2 stories on eli-lilly, across Science.

The Elecsys pTau217 biomarker test helps identify Alzheimer's-related brain changes in patients aged 55 and older with cognitive decline.

Interim Phase I trial data shows a single dose of a gene-editing treatment significantly reduced LDL cholesterol levels in participants.